The CM-Path Biobanking Sample Quality Improvement Tool: A Guide for Improving the Quality of Tissue Collections for Biomedical Research and Clinical Trials in Cancer

Valerie Speirs*, Harriet Foden, Jane Hair, Raffaella Tate, Helen Pitman, Karin Oien, Andrew Hall, Gareth Thomas

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Biobanking is now a key discipline in cancer research and its infrastructure. This helps accelerate translational research and is typically pathology-led. To use biobanked tissues to best effect, sample quality is paramount, and biobanks have a responsibility to ensure this is achieved. In 2016, the National Cancer Research Institute (NCRI) established the Cellular & Molecular Pathology initiative (CM-Path), which aims to re-invigorate UK academic pathology in the UK. One of the goals of the CM-Path biobanking subgroup group was to create a Biobanking Sample Quality Improvement Tool. The tool is a confidential self-assessment of current practices within a biobank, focusing on tissue quality and identifying areas with the potential for improvement. Here we describe the development and implementation of this tool and discuss what it can offer to the cancer biobanking community.
Original languageEnglish
JournalBiopreservation and Biobanking
Publication statusAccepted/In press - 13 May 2020

Fingerprint Dive into the research topics of 'The CM-Path Biobanking Sample Quality Improvement Tool: A Guide for Improving the Quality of Tissue Collections for Biomedical Research and Clinical Trials in Cancer'. Together they form a unique fingerprint.

  • Cite this